Phase 1 Clinical Trial to Evaluate the Safety and Anti-Tumor Activity of AB-201

Conditions: Breast Cancer; Gastric Cancer; Gastroesophageal Junction Adenocarcinoma Interventions: Drug: AB-201; Drug: Cyclophosphamide; Drug: Fludarabine Sponsors: GC Cell Corporation Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials